257 related articles for article (PubMed ID: 20824479)
1. Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.
Zhang Z; Larner SF; Kobeissy F; Hayes RL; Wang KK
Methods Mol Biol; 2010; 662():317-29. PubMed ID: 20824479
[TBL] [Abstract][Full Text] [Related]
2. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and systems biology: application in drug discovery and development.
Chakravarti B; Mallik B; Chakravarti DN
Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of biomarkers of traumatic brain injury.
Wang KK; Ottens AK; Liu MC; Lewis SB; Meegan C; Oli MW; Tortella FC; Hayes RL
Expert Rev Proteomics; 2005 Aug; 2(4):603-14. PubMed ID: 16097892
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Translation of neurological biomarkers to clinically relevant platforms.
Hayes RL; Robinson G; Muller U; Wang KK
Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
[TBL] [Abstract][Full Text] [Related]
7. Identification and elucidation of the biology of adverse events: the challenges of safety assessment and translational medicine.
Turteltaub KW; Davis MA; Burns-Naas LA; Lawton MP; Clark AM; Reynolds JA
Clin Cancer Res; 2011 Nov; 17(21):6641-5. PubMed ID: 22046025
[TBL] [Abstract][Full Text] [Related]
8. The application of systems biology to drug discovery.
Cho CR; Labow M; Reinhardt M; van Oostrum J; Peitsch MC
Curr Opin Chem Biol; 2006 Aug; 10(4):294-302. PubMed ID: 16822703
[TBL] [Abstract][Full Text] [Related]
9. Applying systems biology in drug discovery and development.
Galizzi JP; Lockhart BP; Bril A
Drug Metabol Drug Interact; 2013; 28(2):67-78. PubMed ID: 23612649
[TBL] [Abstract][Full Text] [Related]
10. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.
Kobeissy FH; Sadasivan S; Oli MW; Robinson G; Larner SF; Zhang Z; Hayes RL; Wang KK
Proteomics Clin Appl; 2008 Oct; 2(10-11):1467-83. PubMed ID: 21136795
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
Eifler AC; Thaxton CS
Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
[TBL] [Abstract][Full Text] [Related]
12. Systems biology impact on antiepileptic drug discovery.
Margineanu DG
Epilepsy Res; 2012 Feb; 98(2-3):104-15. PubMed ID: 22055355
[TBL] [Abstract][Full Text] [Related]
13. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
14. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
[TBL] [Abstract][Full Text] [Related]
15. What's next after 50 years of psychiatric drug development: an FDA perspective.
Laughren TP
J Clin Psychiatry; 2010 Sep; 71(9):1196-204. PubMed ID: 20923624
[TBL] [Abstract][Full Text] [Related]
16. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
17. [Network pharmacology: new guidelines for drug discovery].
Liu AL; Du GH
Yao Xue Xue Bao; 2010 Dec; 45(12):1472-7. PubMed ID: 21351485
[TBL] [Abstract][Full Text] [Related]
18. Traumatic brain injury biomarkers: from pipeline to diagnostic assay development.
Oli MW; Hayes RL; Robinson G; Wang KK
Methods Mol Biol; 2009; 566():293-302. PubMed ID: 20058179
[TBL] [Abstract][Full Text] [Related]
19. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling for discovery of novel targets in human traumatic brain injury.
Barr TL; Alexander S; Conley Y
Biol Res Nurs; 2011 Apr; 13(2):140-53. PubMed ID: 21112922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
